At what enterprise value was PATTERSON COMPANIES acquired in 2025?

During the acquisition of PATTERSON COMPANIES by PATIENT SQUARE CAPITAL in 2025, the transaction's Enterprise Value is estimated to be in the range of 3b - 100b USD.

What was the EV/EBITDA of PATTERSON COMPANIES when it was acquired by PATIENT SQUARE CAPITAL?

The estimated EV/EBITDA multiple for PATTERSON COMPANIES is in the range of 5x - 12x.

What was the revenue of PATTERSON COMPANIES at the time of the deal?

The revenue of PATTERSON COMPANIES at the time of the deal is estimated to be in the range of 2.5b - 5b USD.

What was the EBITDA of PATTERSON COMPANIES during the acquisition?

PATTERSON COMPANIES's EBITDA is estimated to be in the range of 250M - 500M USD.

How is the data for the PATTERSON COMPANIES acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the PATTERSON COMPANIES deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.pattersoncompanies.com/news/patterson-companies-completes-aaquisition-by-patient-square-capital/

← DATABASE

Home Database Healthcare & PharmaPATTERSON COMPANIES

04/2025

PATTERSON COMPANIES acquired by PATIENT SQUARE CAPITAL

UNITED STATES Life Sciences / Medical Devices / Medical Consumables EV 3b - 100b USD

Context

Patient Square Capital completed the acquisition of 100% of Patterson Companies, taking the business private and delisting it from the NASDAQ Global Select Market. Patterson will maintain its headquarters in St. Paul, Minnesota. The transaction positions Patterson to accelerate its growth strategy and strengthen its offering to dental and animal health customers under Patient Square's healthcare-focused ownership and operational support.

PATTERSON COMPANIES, which reported an EBITDA margin of in 2024, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Patterson Companies is a leading US-based distributor of products and services to two distinct end markets: (1) dental, providing dental practitioners and laboratories across North America and the UK with consumables, equipment, technology solutions, and value-added services; and (2) animal health, supplying veterinary practices and production animal operations through its Animal Health International subsidiary. The company operates a comprehensive portfolio combining product distribution with proprietary software, digital solutions, and practice management services, supported by an extensive logistics and supply chain network across North America and the UK.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (USD)

Year

Rev

EBITDA

EBIT

2024

2023

Similar deals in Life Sciences

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
05/2025	OTTOBOCK	MATTON ORTHOMEDI	BELGIUM	Implants & Prosthetics
05/2025	IK PARTNERS	BIOBANK	FRANCE	Implants & Prosthetics
04/2025	IK PARTNERS	STERIMED	FRANCE	Medical Consumables
04/2025	NORGINE	THERAVIA	FRANCE	Generics / Labs
04/2025	INSTITUT MERIEUX / ARCHIMED	CEVA SANTE ANIMALE	FRANCE	Animal Health
04/2025	CINVEN	NUTRISENS	FRANCE	Nutrition & Dietary Supplements
03/2025	LBO FRANCE	HEMODIA	FRANCE	Medical Devices
03/2025	ZYDUS	AMPLITUDE SURGICAL	FRANCE	Implants & Prosthetics
03/2025	NUTRISENS	PRODIET	BRAZIL	Nutrition & Dietary Supplements
03/2025	SIPAREX	LABORATOIRE POLIDIS	FRANCE	Medical Consumables

REFERENCES

Valuation range: EV 3b - 100b USD

Revenue range: 2.5b - 5b USD

EBITDA range: 250M - 500M USD

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of PATTERSON COMPANIES by PATIENT SQUARE CAPITAL are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Target: patterson companies

Acquirer: patient square capital